Measles Cases Detected at Major US Airports During Holiday Season
This holiday season has seen the detection of one of the most infectious diseases, measles, at several prominent airports across the United States. During December, airports such as Raleigh-Durham International, Boston Logan, Newark Liberty, and Denver International have all reported varying instances of potential measles infections.
A representative from the Massachusetts Department of Public Health (MDPH) explained that the agency typically receives notifications about possible measles cases from state healthcare providers and public health agencies, including the CDC, when infections emerge elsewhere.
To assess and confirm the locations and timelines of potential exposures, MDPH combines patient interviews with travel itinerary reviews. If there’s a chance of exposure occurring in a public setting—like at an airport—they coordinate with relevant authorities.
“Public exposure decisions often involve collaboration with other agencies,” noted a spokesperson.
Meanwhile, a spokesperson for the New Jersey Department of Health (NJDOH) mentioned that cases can be reported immediately. They added that clinicians need to report any suspected measles cases based on symptoms, regardless of whether test results are available.
According to AAA, this holiday season is set to witness a record-breaking 8.03 million travelers flying across the country.
Confirming a measles case necessitates lab testing or direct contact evidence with an infected individual. Local health departments engage in thorough investigations, interviewing those potentially exposed.
In New Jersey, a “suspected case” is described as one exhibiting clinical symptoms suggestive of measles without yet having laboratory confirmation. “Probable cases,” on the other hand, show symptoms consistent with measles but lack confirmatory tests or known connections to confirmed cases.
Local health departments strive to piece together a complete timeline of exposure locations.
In Massachusetts, the MDPH takes various factors into account during case investigations. These include clinical presentation, vaccination and travel histories, lab data, and evidence linking back to confirmed cases. They encourage healthcare providers to send two types of specimens—nasopharyngeal or oropharyngeal swabs for PCR testing and serum for IgM blood testing—to their state public health laboratory.
If any case is reclassified or excluded later on, public health recommendations might change as new information surfaces.
As of December 30, the CDC reported 2,065 measles cases in the U.S., with 11% resulting in hospitalization. Tragically, three deaths due to measles were confirmed in 2025.
Health experts note that typical measles symptoms include high fever, cough, runny nose, watery eyes, and a rash that usually unfolds three to five days post-symptom onset. The rash typically starts as flat red spots at the hairline and spreads downward.
Measles is airborne and can linger in the air for up to two hours after an infected person exits an area. Anyone suspecting they’ve been exposed, particularly individuals who are unvaccinated or uncertain of their vaccination status, should reach out to a healthcare provider promptly. Monitoring symptoms and avoiding contact with others is also advised.
The CDC advises those without documented measles immunity to receive the MMR vaccine. They clarify that if someone has prior immunity, it’s safe to get the vaccine again, and healthcare providers may conduct blood tests to check for immunity evidence.
